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European regulatory frameworks for chemicals (i.e. registered under REACH, plant protection products (PPPs),
biocides, human and veterinary medicinal products) require that substances undergo an assessment to identify
whether they are persistent (P), bioaccumulative (B) and toxic (T), or very persistent (vP) and very bioaccumulative
(vB), i.e. to identify them as PBT substances or vPvB substances according to their properties. We screened current
practices, evaluated possibilities and made a proposal for a harmonised assessment. Our proposal assumes that it
should be possible to identify PBT and vPvB substances on the basis of the data available according to the
requirements of the respective legal frameworks. For substances registered as PPPs and mostly also biocides and
medicinal products, a ‘definitive assessment’ is often possible. Within REACH, the registrant has to provide all
information necessary for PBT assessment regardless of the yearly tonnage of chemicals. But in cases of limited data
availability, we suggest using a weight of evidence approach to account for such differences in data availability and
type of data across different frameworks and to make use of valuable additional information. We propose to base the
evaluation of persistence on degradation half-lives and to normalise a number of parameters (e.g. type of kinetics used,
temperature). But further work is needed, e.g. for deriving DegT50 for water and sediment compartments. For the
B-criterion, information other than BCF in fish could be considered and more information related to bioaccumulation
processes should be gathered (e.g. in species other than fish, different uptake routes). Testing for T identification is
focused on standard aquatic species but could also be complemented by e.g. information from other species.
Information such as those read-across from structurally related substances and QSAR are often of importance for
screening assessments. The aim of PBT and vPvB identification is to reliably target the problematic substances, with
as few false negatives or positives as possible, regardless of the regulatory framework. Each aspect was thus
considered in the context of the others for a final balanced decision. As the need for conservatism is interpreted
differently under the various frameworks, harmonizing this identification is a challenging task.
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The different European substance regulations (e.g. REACH
[1], plant protection products regulation [2], biocidal prod-
ucts regulation [3], human and veterinary medicinal prod-
ucts regulations [4,5]) have all recognised that substances
that are either persistent (P), bioaccumulative (B) and
toxic (T) (PBT substances) or very persistent (vP) and
very bioaccumulative (vB) (vPvB substances) must be* Correspondence: caren.rauert@uba.de
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in any medium, provided the original work is pconsidered as hazardous for the environment due to
their potential for eliciting long-term adverse effects.
The goal of preventing exposure of humans and the envir-
onment to PBT and vPvB substances is thus shared among
all EU-based regulatory frameworks. In a comparison be-
tween different European and International regulations,
Moermond et al. [6] reported that there are differences in
how this goal is achieved, not only regarding technical cri-
teria but also conceptual criteria (e.g. regulatory conse-
quences for PBT and vPvB substances).
In terms of numerical criteria, the identification of PBT
and vPvB substances is based on substance propertiesn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Rauert et al. Environmental Sciences Europe 2014, 26:9 Page 2 of 13
http://www.enveurope.com/content/26/1/9which are addressed by the same trigger values in all
European substance regulations (see Table 1).
Therefore, it could be assumed that the identification
of a PBT or vPvB substance should be independent of
both the use of the substance and the regulatory frame-
work under which it is assessed. However, the decision
on whether a substance fulfils the PBT or vPvB criteria
not only depends on substance properties, but also on
the framework under which the substance is evaluated.
For substances whose properties are near the trigger
values, this decision may differ due to differences between
the different legal frameworks in
(i) The assessment procedures,
(ii) The interpretation of PBT/vPvB criteria,
(iii) Available data within the assessment process
(see next subsection), and
(iv) The regulatory consequences
Although based on the same principle (i.e. avoiding
emissions of potentially harmful substances to the envir-
onment), the mandatory measures imposed by regulation
for a substance identified as a PBT or vPvB vary between
the different regulatory frameworks:
– For substances registered under REACH, the revised
Annex XIII [7] not only gives the criteria but also
the information relevant for the screening and
assessment of P, vP, B, vB and T properties. Also,
ECHA provides extensive guidance on PBT/vPvB
assessment [8,9]. Substances of very high concern
(SVHC) (e.g. PBT/vPvB) are included in the
‘candidate list’ for authorisation, based on the
outcome of the scientific assessment of intrinsic
properties. Substances on the ‘candidate list’ can
then be prioritised for authorisation and finally listed
in Annex XIV of the REACH regulation. Some
substances may be listed with specific exemptions
that do not require authorisation. For eachTable 1 PBT and vPvB criteria across the various European su
Criterion PBT identification
Persistence • Half-life (degradation) > 60 days in marine water, or
• Half-life (degradation) > 40 days in fresh or estuarine
• Half-life (degradation) > 180 days in marine sediment
• Half-life (degradation) > 120 days in fresh or estuarine
• Half-life (degradation) > 120 days in soil
Bioaccumulation • BCF > 2,000 L/kg
Toxicity • NOEC (long-term) < 0.01 mg/L for marine or freshwat
• Classification as carcinogenic (category 1 or 2), mutag
1 or 2), or toxic for reproduction (category 1 or 2), or
• Other evidence of chronic toxicity, as identified by th
STOT RE 1 or STOT RE 2 pursuant to Regulation (EC) Nsubstance included in Annex XIV, a deadline will be
set after which use of that substance in the EU must
stop (known as the ‘sunset date’), unless authorized
by the European Commission.
– The EU Biocidal Products Regulation [3] refers to
Annex XIII of REACH [7] and to the ECHA
guidance for PBT/vPvB assessment [8,9]. However,
for biocides, generally no authorisation will be
granted for products containing substances
identified as PBT or vPvB. Additionally, biocides
that fulfil two of the three criteria are flagged as
candidates for substitution and are subjected to a
comparative assessment.
– For the assessment of veterinary medicinal products,
guidance has been developed by the European
Medicines Agency [10], which also refers to ECHA
guidance [8,9]. A benefit-risk analysis is conducted
in support of the decision on whether to authorise
the substance or not [5]. In this context, an
identification as a PBT substance is generally
regarded as a serious concern.
– For medicinal products for human use (which are
usually emitted via sewage treatment plants), no
restrictions are envisaged as human health is
prioritised over environmental issues [4]. ECHA
guidance [8,9] is used for the assessment.
– By contrast, the PPP Regulation [2] simply stipulates
the PBT/vPvB criteria, oblivious to any other
guidance. As for biocides, no authorisation will be
granted for those substances identified as PBT or
vPvB. Additionally, PPPs that fulfil two of the three
criteria are flagged as candidates for substitution and
are subjected to a comparative assessment, as is the
case for biocides. The draft guidance developed by
DG Sanco [11] focuses primarily on the
identification of candidates for substitution.
Although the substances differ in their properties,
uses, exposure pathways and regulatory consequences,bstance regulations
vPvB identification
• Half-life (degradation) > 60 days in marine, fresh or
estuarine water, or
water, or
, or • Half-life (degradation) > 180 days in marine, fresh or
estuarine sediment, or
sediment, or
• Half-life (degradation) > 180 days in soil
• BCF > 5,000 L/kg
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pend on the framework under which they are evaluated,
since the protection goals do not differ. This will avoid
situations where a substance with different uses is iden-
tified as a PBT substance under one regulation, and not
under another. This is relevant because, for example,
many biocides are also used as PPPs or veterinary medi-
cinal products. Since regulatory authorities should aim
at making predictable and consistent decisions, a strat-
egy for harmonised PBT identification across the differ-
ent frameworks is needed. The focus of this paper is on
the assessment procedure; it proposes a reasonable in-
terpretation of the available data while considering not
only substance properties but also keeping in mind the
regulatory consequences.
Dealing with differences in data requirements and
data availability between regulatory frameworks
For substances registered as plant protection products
(PPPs), as well as most biocides and medicinal products,
requirements for environmental risk assessment usually
include sufficient information for PBT/vPvB identifica-
tion. Therefore, a ‘definitive assessment’ based on a dir-
ect comparison to the trigger values (see Table 1) of the
three criteria should be possible in most cases.
For chemicals registered under REACH, data require-
ments depend on the quantities which are manufactured
or imported per year; for high production volume (HPV)
chemicals, more data has to be provided, and for sub-
stances below 10 t/a, only a basic data set is mandatory.
Table 2 provides an overview of test requirements for
persistence. The registrant also has to provide all infor-
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substances > 10 t/a
One simulation study in the ‘compartme
substances >100 t/a if not readily biodegthe tonnage manufactured or imported annually. How-
ever, the necessary information is not always included in
the dossiers so a direct comparison of measured data with
the criteria is not always possible. Unfortunately, in many
cases, registrants submitted dossiers which show deficien-
cies and do not comply with the requirements of REACH
or the Technical Guidance Document, e.g. necessary tests
are missing [12,13]. In such cases, only a ‘screening assess-
ment’ can be performed. In such an assessment screening
information such as that listed in Annex XIII of REACH
[7] should be considered; this should be supplemented by
data from non-standardised tests and from the literature,
by information on relevant endpoints based on quantita-
tive structure-activity relationships (QSARs) if adequately
documented as well as by read-across from structurally re-
lated substances or grouping approaches. Only if the avail-
able information is considered unreliable or insufficient
and/or does not permit a conclusion on each criterion to
be drawn with sufficient confidence, additional testing will
be necessary.
Because of the large differences in data requirements
across the different frameworks and type of data (e.g.
QSARs, non-standardised tests), we recommend consider-
ing all available information in a weight of evidence (WoE)
approach - as suggested in REACH (Annex XI 1.2 of [1]).
The WoE approach means that all available information
is assessed through expert judgement for its suitability
and reliability, and relative weights are assigned (e.g.
quality of the data, consistency of results and/or data,
nature and severity of effects, relevance of the informa-
tion for the given regulatory endpoint). The use of this
WoE approach depends on the amount of information
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sion [14]. The WoE approach also has the advantage,
such that it uses valuable additional information whose
submission is not mandatory (e.g. field data, alternative
testing strategies). This approach is proposed in REACH,
and we suggest that it should also be used to improve
PBT assessment under the other frameworks in cases
where it could deliver valuable additional information.Discussion
Persistence, bioaccumulation and toxicity criteria
In this chapter, we introduce the three criteria, i.e. per-
sistence (P), bioaccumulation (B) and toxicity (T). The
general scheme is to test sequentially for P, then B and
lastly for T, as only substances with high persistence must
be considered further for PBT identification. This se-
quence is further justified by the need to limit testing for
animal welfare reasons.
A substance is considered a PBT or vPvB substance if
it fulfills the P, B and T or the vP and vB criteria. In the
following sections, for each PBT criterion, the criteria
for the ‘definitive assessment’ are presented first. This is
followed by the criteria for the ‘screening assessment’,
which is carried out in cases of limited data availability.Persistence
The persistence of a substance in soil, water or sediment
is controlled by its intrinsic properties and also influ-
enced by environmental conditions (e.g. temperature,
presence of degraders, pH, moisture content in case of
soil, bioavailability of the substance). The assessment of
persistence is influenced by the type and quality of avail-
able studies and also by the interpretation of the avail-
able data.
Persistence is not characterised consistently in the dif-
ferent frameworks, but, as suggested by Boethling et al.
[15] and in [9], it is the degradation half-life (DegT50)
which should be compared to the trigger values in the
various compartments, as a mere transfer (dissipation)
from one compartment to the other does not affect the
persistence of a substance. DegT50 values are commonly
estimated from the parent substance in extractable resi-
dues in degradation simulation studies performed accord-
ing to e.g. OECD test guidelines 307, 308 or 309 [16-18].
In the context of PBT identification, DT50 should not
refer to dissipation half-lives (DissT50) as these refer to
cases where the substance may not be degraded but only
redistributed (e.g. from the water phase to sediment or
the atmosphere, or leaching, run-off, volatilisation or up-
take into plants). This is explicitly mentioned in the re-
vised Annex XIII of the REACH regulation [7], while the
PPP Regulation [2] only refers to half-lives in general.Definitive assessment. If degradation simulation tests
have been conducted to meet legal requirements, a suffi-
cient amount of reliable data is usually available to
complete a definitive assessment by comparing the DegT50
values directly to the criteria as reported in Table 1. How-
ever, a number of issues related to these values should be
addressed.
Type of kinetics for deriving DegT50. We suggest
using single first-order (SFO) kinetics to derive DegT50
values for the purpose of comparing them to the trigger
values. Best fit kinetics such as first-order multi-
compartment (FOMC) can be used if they are recalcu-
lated by dividing the DegT90 values by a factor of 3.32 or
by using the degradation rate constant of the slower
phase in case of double first-order in parallel model
(DFOP) or Hockey stick (HS) kinetics. This proposal is
based on the Guidance Document on Estimating Persist-
ence and Degradation Kinetics from Environmental Fate
Studies on Pesticides in EU Registration [19]. This docu-
ment gives detailed guidance on the derivation of DegT50
values, which is used for risk assessment of biocides, medi-
cinal products and PPPs and could be applied to other sub-
stance groups as well.
Normalisation of the DegT50 to specific conditions.
Variable conditions such as temperature, humidity, mi-
crobial populations and others have a large influence on
the rate of degradation of a chemical substance. Simula-
tion studies in the laboratory are conducted at various
temperatures: OECD test guidelines 307 and 308 on
transformation in soil and in water-sediment systems
[16,17] recommend testing at 20°C and 10°C (if the sub-
stance is used in colder climates), the US EPA recom-
mends 22°C for soil testing [20] and for many pesticides,
tests have been performed both at 20°C and 10°C. For
the purpose of comparing different data, half-lives should
thus be normalised to a defined temperature since it is a
criterion which strongly influences the outcome of a deg-
radation test and, furthermore, is quantifiable unlike other
related criteria such as differences in microorganism pop-
ulations. For PBT identification, normalisation of DegT50
values to a temperature of 12°C has been applied to many
biocides and other chemicals, as prescribed in the TGD
[21], and is included as an option in the REACH guidance
on information requirements and chemical safety as-
sessment (Chapter R.7b [8]). This temperature of 12°C
is also included in the draft ‘Guidance on the assess-
ment of persistent, bioaccumulative and toxic (PBT) or
very persistent and very bioaccumulative (vPvB) sub-
stances in veterinary medicine’ [22]. By contrast, DegT50
values for PPPs are normalised to 20°C, both for labora-
tory and field data for risk assessment; this temperature
has also been proposed for PBT identification [11]. For
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normalising the DegT50 values to 12°C because this
temperature is established or suggested under the majority
of frameworks (i.e. Biocides Regulation, REACH and me-
dicinal products Directives).
Degradation in soil: inclusion of field studies. Labora-
tory simulation studies can provide information on both
route and rate of degradation. This permits the estima-
tion of primary degradation rates (DegT50), as well as
the measurement of carbon dioxide evolution and of for-
mation of metabolites and bound residues. But the small
size of the test systems is a limiting factor for both the
test duration and the diversity of the microbial population
(which may limit the probability of having competent de-
graders and which usually also decreases over time).
For PPPs, terrestrial field (dissipation) studies under
realistic outdoor conditions are required when the DegT50
exceeds 60 days at 20°C in laboratory studies [2]. Such
field studies allow DT50 values to be derived under condi-
tions going beyond the limitations of laboratory tests. A
number of conditions may be more realistic compared to
laboratory studies (e.g., prolonged duration, fluctuating
temperature and humidity, higher biological activity, lar-
ger test system), but may not be as easy to compare or
reproduce. A limiting aspect in such testing is that a dissi-
pation half-life, and not a degradation half-life, will be
derived. The measured residues result from biotic degrad-
ation but also from photolytic transformation and field
dissipation processes like volatilisation, leaching and run-
off. However, a novel approach to estimate a DegT50 in
field studies has recently been proposed by EFSA [23] in
which dissipation processes on the soil surface are esti-
mated separately from biodegradation in the soil compart-
ment. This DegT50 has to be normalised for temperature
and humidity for comparability reasons. Although this
guidance was developed for the evaluation of persistence
of PPPs in field studies, in principle, its rationale and
approach should also be applicable to other types of sub-
stances. Thus, we suggest including field studies in persist-
ence assessment as additional data, provided that it is
possible to derive DegT50 values. This is in line with the
WoE approach, which considers all available information
in the decision process.
Evaluation of DegT50 values for the water and sediment
compartments. There is no standardised test that mea-
sures true degradation only in the sediment compart-
ment. The test on ‘aerobic and anaerobic transformation
in aquatic sediment systems’ (OECD test guideline 308
[17]) is generally used to assess the fate of compounds
in water and sediment systems, but reliable separate
DegT50 values for water and for sediment cannot usually
be derived from the study results. Therefore, separateDegT50 values are generally not available for comparison
with the trigger values.
Available DT50 values for the water phase in many
cases only refer to dissipation, as many substances, espe-
cially those with high log KOC and low water solubility,
are quickly transferred to the sediment. The Aerobic
Mineralisation in Surface Water – Simulation Biodeg-
radation Test (OECD 309 [18]) is available to measure
degradation in the water phase, but to date it has rarely
been used for the assessment of environmental fate.
We suggest comparing the DegT50 of the total system
to the two trigger values for water and sediment. More
specifically, in the case of a substance that is rapidly
transferred into the sediment, the DegT50 of the total
system should be compared with the trigger value for
sediment (120 and 180 days for persistence assessment).
For substances that mostly remain in the water phase,
the DegT50 values should be compared with the trigger
values for water (40 and 60 days for persistence assess-
ment). There will be many cases where a substance can
be found in both the water and sediment phases, which
means that clear criteria are necessary to judge which of
the trigger values is appropriate.
Selection of an adequate DegT50 from multiple studies.
As explained above, testing requirements for persistence
differ greatly between regulatory frameworks. The infor-
mation is summarized in Table 2.
If several valid degradation studies for one compartment
are available, their quality and reliability are an important
consideration. We propose the following approach to pro-
cessing the information gathered:
– When a small number of studies is available (i.e. up
to 4 DegT50 values), we suggest selecting the
worst-case DegT50 rather than performing a weak
statistical evaluation.
– When more studies are available (i.e. 5 and more
DegT50 values), various approaches are possible:
The most conservative approach would be to use
the worst-case DegT50;
A less conservative approach is the geometric
mean, which gives a medium degradation rate, but
does not provide information on the range of
variability of the values and may produce some
false negatives, i.e. fail to recognise some
persistent substances;
An intermediate approach is the 90th percentile
which may produce some false positives.
– In cases where the studies are not equally reliable,
the range and distribution of all available DegT50
values should be examined in the WoE approach.
This is done by assigning different weights to them
according to the quality of the studies, in order to
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represent the persistence of the substance.
If five or more DegT50 values are available, we suggest
selecting the geometric mean. This is to be considered
together with the decision to normalise the DegT50
values to a temperature of 12°C, in order to achieve an
overall reasonable conservatism (i.e. target the problem-
atic substances).
This choice is illustrated by the evaluation of a number
of substances (64) with 5 and more soil laboratory DegT50
values available, whose the degradation data have been re-
cently assessed as part of the regular national PPP regis-
tration process in Germany. This exercise indicates how
many substances would be identified as P, on the basis of
the above evaluation parameters.
– For degradation in soil, only data from laboratory
studies was used. Field studies were excluded since
no evaluations according to the new EFSA scientific
opinion [23] were available yet.
– For water-sediment studies, the total system DegT50
was used and compared to the sediment value of
120 days.
– Temperature was normalised both to 12°C and 20°C;
– The maximum DegT50 value (worst-case scenario)
and the geometric mean of all DegT50 were used.
The results indicate that the percentage of substances
fulfilling the P criterion varies from about 39% for the least
conservative approach (20°C and geometric mean) to 73%
for the most conservative approach (12°C and maximum
DegT50) and is intermediate (i.e. about 53%) when the geo-
metric mean and a temperature of 12°C are used (Table 3).
Screening assessment
For many chemicals, especially those registered under
REACH, only a limited data set is available, as explained
in Chapter 2. In this case, the assessment of persistence
has to be based on screening data. If no further data are
presented, the result of the screening assessment (i.e.Table 3 Estimation of percentages of substances fulfilling P c









This evaluation was performed with a dataset of 64 PPP.screening P) should be used for further regulatory action
unless refuted by more definitive data such as valid
simulation test data.
In the screening approach, the evaluation of persist-
ence is mainly based on tests on ready biodegradability
(OECD 301 A-F [24] and OECD 310 [25]).
Substances which are readily degradable are consid-
ered not to be persistent (not P) [26], as the test is fairly
stringent. Due to the high rate of mineralisation, an accu-
mulation or formation of relevant metabolites is improb-
able. On the other hand, substances that are not readily
biodegradable are considered to be potentially persistent
(potentially P, sometimes also called ‘screening P’), until
further data are presented. Due to the stringency of the
test, this results in a high number of false positives; thus,
‘enhanced ready biodegradability’ tests (based on ready
biodegradability tests but with prolonged test duration,
higher concentration of microbial biomass, increased test
volumes, but no pre-adaptation) may be used for chemi-
cals registered under REACH to prove their degradability
without having to conduct more expensive and time-
consuming simulation studies.
Other available data on persistence also have to be ex-
amined. This may include data on abiotic degradation,
monitoring data, QSAR estimations and read across from
structurally related substances.
Main outcomes and open points
Our proposal is to base P identification on degradation,
and not on dissipation, as recommended previously [6,17].
Thus, trigger values should be compared to DegT50 values.
The final identification of substances as persistent should
be based on a reasonable conservatism for the various
regulatory frameworks and not on a combination of vari-
ous worst-case choices. Our proposal is summarised in
Table 4.
It should be noted that in the P assessment, other in-
formation generated in degradation simulation studies
such as the formation of non-extractable residues (NER)
or the mineralisation rate are not formally considered.
Such information can only be taken into account in ariterion
rsistent in soil only Persistent in w/s system only Total
17% 11% 73%
(11 of 64) (7 of 64) (47 of 64)
8% 13% 55%
(5 of 64) (8 of 64) (35 of 64)
3% 20% 53%
(2 of 64) (13 of 64) (34 of 64)
3% 22% 39%
(2 of 64) (14 of 64) (25 of 64)
Table 4 Main elements of our proposal for a harmonized
assessment of persistence across regulatory frameworks
Persistence
Definitive assessment Screening assessment
Criteria Half-life Ready biodegradability
Water: Enhanced ready
biodegradability
> 60 days in marine
(>60 days)
> 40 days in fresh- or
estuarine (>60 days)
Sediment:
> 180 days in marine
(>180 days)
> 120 days in fresh- or
estuarine (>180 days)
Soil:
> 120 days (>180 days)




Normalising DegT50 to 12°C Abiotic degradation
Inclusion of field studies if





For ≤4 values: worst case Read-across from
structurally related





Values of water and
sediment; need clear
criteria
Other information to consider
Formation of NER or
mineralisation rate
The P and vP criteria are included for definitive and screening assessments.
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are the result of degradation and incorporation into the
microbial biomass, their formation can be considered as a
detoxification step. On the other hand, where the original
substance may be remobilised, NER formation should be
interpreted as a specific form of compound persistency.
The issue of NER is currently being examined in various
contexts [27-29].Bioaccumulation
Substances with a high potential for bioaccumulation are
of special concern even if introduced into the environ-
ment in low concentrations. They are taken up by biota
and their concentrations in the tissues result from the
combination of uptake and depuration. Uptake occurseither via the surrounding medium - water or soil - (bio-
concentration), food (dietary bioaccumulation) or the food
chain (biomagnification). These processes are driven by
the properties of the substance (mostly hydrophobicity as
determined by octanol/water or octanol/air partition coef-
ficient, i.e. KOW or Koa, as well as other characteristics, e.g.
protein-binding properties) but they also depend on the
environmental matrices (i.e. aquatic, terrestrial) and on
the biological, ecological and trophic characteristics of the
organisms.
The bioconcentration factor (BCF) is the usual basis
for defining the B criterion in PBT assessment although
it is not always the most relevant indicator of the envir-
onmental bioaccumulation potential of a substance, as
stated in [30]. Indeed other available data (e.g. monitoring
data, biomagnification, bioaccumulation in other species,
literature data) should also be taken into account [30-32].
We propose therefore that all available relevant informa-
tion on bioaccumulation should be considered in a WoE
approach.
Definitive assessment. The definitive assessment of the
bioaccumulation potential is based on the bioconcentra-
tion factor (BCF) in an aquatic species. The trigger value
for the BCF is set at >2,000 L/kg for B assessment and
at >5,000 L/kg for vB assessment.
Bioconcentration. The bioconcentration factor (BCF) is
defined as the ratio of concentration in fish to the con-
centration in the surrounding medium. It is generally
derived experimentally according to OECD Test Guide-
line 305 I (bioconcentration flow-through fish test [33]).
This test is appropriate for substances with moderate
hydrophobicity, so it is necessary to determine the con-
centration of the test substance in the exposure medium
and in fish. The test is mandatory for risk assessment for
PPPs, biocides and human medicinal products if log KOW
exceeds 3, and for veterinary pharmaceuticals if log KOW
exceeds 4. It is also required for REACH substances with
a production volume above 100 t/a and a log KOW >3.
The BCF should be normalised to a lipid content of
5% of total body weight (average lipid content of fish
commonly used in [33,34]). Potential growth dilution
should also be taken into account [26,33], as well as in-
dications of slow or poor depuration.
Bioaccumulation and biomagnification. Bioaccumula-
tion and biomagnification should also be taken into ac-
count for species such as fish since the relevant route of
exposure may be the food, especially for substances with
high log KOW and for substances poorly soluble or non-
soluble in water. Indeed for such substances, it may be
technically difficult or not feasible (i) to conduct a bio-
concentration fish test since aqueous exposure via gill
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http://www.enveurope.com/content/26/1/9uptake is reduced and no longer accounts for the dom-
inant exposure pathway, and/or (ii) to analyse the con-
centration in water. Instead, a dietary fish test has been
developed to determine uptake by ingestion, yielding a
biomagnification factor (BMF) [33].
A BMF >1 is a supportive indication of high bioaccumu-
lation and the B criterion is thus considered as fulfilled.
Nevertheless, a definitive trigger value for BMF has not
yet been established. Hence, a bioaccumulation potential
cannot be excluded in cases of BMF < 1. Recalculation of
the dietary study data into aquatic BCF values has been
suggested [26] but these methods have to be checked
carefully for their domain of applicability [35].
Supplementary information. Other reliable data should
also be considered, when available:
– High bioaccumulation in organisms other than fish,
as mentioned in the Stockholm Convention [36] and
the revised Annex XIII criteria in REACH [7]; e.g.
bioaccumulation in mussels [37] or oligochaetes
[38]. In some cases, lipid normalisation
concentrations should be revised since a
normalisation to a lipid content of 5% of the body
weight - as proposed for fish (see above) - may not
be suitable for species with low lipid content
(e.g. mussels);
– Indicators other than BCF calculated from
environmental data (i.e. measured in mesocosms or
in the field), assessing the accumulation of
substances from water and diet such as the
bioaccumulation factor (BAF), their specific
accumulation in food webs expressed as
biomagnification factor (BMF) or trophic
magnification factor (TMF);
– Bioaccumulation via different uptake routes, e.g.
terrestric or benthic oligochaetes [38,39]. As
bioaccumulation may differ between water- and
air-breathing organisms, aquatic bioaccumulation
data should not be transfered to air-breathing
organisms [31];
– Accumulation in specific tissues, e.g. substances
such as PCBs accumulate extensively in fatty tissues
and organs from wildlife samples [40]. In some
cases, inefficient or nonexistent detoxification
processes may be responsible for high BCF values
(e.g. TBT in molluscs) [41,42].
– Non-lipid-based accumulation for substances such
as perfluorinated acids, which bioaccumulate in
blood plasma proteins [43,44]. Perfluorooctane
sulfonate (PFOS) can be considered as
bioaccumulative even though the BCF is below the
trigger value (<2,000) but it has a long half-life, high
toxicity and high biomagnification.– Toxicokinetic and chronic studies with mammals
as well as in vitro data on aquatic bioaccumulation
as required for human toxicological assessment are
also available.Screening assessment. The screening criterion for asses-
sing bioaccumulative properties is derived from the hydro-
phobicity of the compound. A substance is considered to
potentially fulfil the B criterion when log KOW exceeds a
value of 4.5 [21].
Suitable quantitative structure-activity relationship
(QSAR) models for estimating the BCF could be used if
log KOW is between 4.5 and 6, as the available BCF
QSAR models are linear between log KOW 2 to 6 [21,45].
For highly hydrophobic substances (log KOW > 6), the po-
tential for bioaccumulation must be assessed through ex-
pert judgement and on a case-by-case basis, taking into
account the specific physico-chemical properties of the
substance (e.g. molecular size and weight, log KOW) and
the available BCF QSAR models (e.g. parabolic equation
in [21,46]).
Since hydrophobicity does not drive all bioaccumula-
tion processes, other information has to be considered,
e.g. surface activity, structural alerts, high log KOA (octa-
nol/air partition coefficient) as an indicator of a possible
bioaccumulation in air-breathing organisms or read-across
approaches from structurally related substances.Main outcomes and open points. Our proposal (see
Table 5) is to consider all available endpoints in addition
to the BCF for aquatic organisms in the WoE approach,
as there are other standardised tests resulting in the
derivation of other BAFs (e.g. benthic oligochaetes [38];
terrestric oligochaetes [39]) and BMFs (fish dietary test
guideline [33]). Currently, a comparison between the re-
sults of these tests (e.g. BMF, BAF) and a BCF is difficult
to make for several reasons such as different uptake
mechanisms of different taxa. Also, in vitro tests for bio-
accumulation (e.g. [47]) are being developed and using
information from field studies and TMF (e.g. [42,48]) is
being considered. Taking into account these various as-
pects will improve the assessment of bioaccumulation.Toxicity
For substances with high persistence and bioaccumula-
tion potential, i.e. fulfilling the P and the B criteria, long-
term exposure of organisms can be expected, which may
cover the whole life-span of the exposed organisms and
even several generations. Therefore, long-term and/or
chronic ecotoxicity data, ideally covering the reproduct-
ive stages, should be used for assessing the T criterion in
the context of a PBT assessment.
Table 5 Main elements of our proposal for a harmonized assessment of bioaccumulation across the regulatory
frameworks
Bioaccumulation
Definitive assessment Screening assessment
Criteria BCF > 2,000 L/kg (>5,000 L/kg) Log KOW > 4.5
Proposal BCF (normalised to 5% lipid content) QSAR if log KOW is between 4.5 and 6, log KOW > 6: expert judgement,
case- by-case
For high log KOW and poorly soluble or non-soluble:
consider BAF, BMF (BMF > 1 indicative)
Other information to consider
Other information to consider Surface-activity
High bioaccumulation in species other than fish Structural alerts
Different uptake routes High log KOA for air-breathing organisms
Accumulation in specific tissues Read-across from structurally related substances.
Non-lipid based accumulation
Toxicokinetic and chronic studies with mammals
In vitro data on aquatic bioaccumulation
The B and vB criteria are included for definitive and screening assessments.
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ion in any of the following situations:
1. Long-term or chronic NOEC or EC10 values from
ecotoxicological tests with aquatic organisms are
below the trigger of 0.01 mg/L, or
2. It is classified as carcinogenic, categories 1 and 2
[49] or 1A and 1B [50], mutagenic, categories 1 and
2 [49] or 1A and 1B [50] or toxic for reproduction,
categories 1, 2 and 3 [49] or 1A, 1B and 2 [50],
so-called CMR substances, or
3. There is other evidence of chronic toxicity, as
identified by the classification of the substance as T,
R45, R46, R48, R60 and R61 or Xn, R48, R62, R63,
R64 [49], or specific target organ toxicity and
repeated exposure (STOT RE category 1 or 2) [50].
If any classification criteria under 2 or 3 are met, there
is no need to perform any further aquatic studies for
evaluation of toxicity.
Supplementary information. When substances such as
PPPs and biocides (i.e. produced to control pests) are
tested for toxic effects, it is likely that these will occur
both in the target species and in non-target species be-
longing to the same taxonomic group. Testing for the T
criterion refers only to aquatic organisms. However, ef-
fects on non-aquatic species could be relevant as well,
bearing in mind, however, that the use of vertebrates for
testing should generally be minimised.
In this context, we recommend that other reliable data
should also be considered where available:
– For PPPs and biocides, results of subchronic,
chronic or reproduction studies with birds andmammals may be available. In this context, a NOEC
of ≤30 mg/kg food in a long-term bird study should
be considered as an indication that the T criterion is
met [21,26].
– It could be relevant to use toxicity data from long-
term ecotoxicological tests on terrestrial organisms,
e.g. OECD TG 222 [51]. However, in such a case, it
has to be clarified whether such an assessment
should (i) be based on trigger values comparable to
those used in the assessment of toxicity for aquatic
organisms (e.g. <0.01 mg/kg dry soil), and (ii) take
into account differences in the exposure of the re-
spective organisms.
– For substances with high log Kow, tests performed
with sediment-dwelling species may provide better
information than tests with pelagic species. Indeed,
the results may be more reliable if the substance
partitions out of solution. Also, the information
gathered may be more useful if it is focused on the
compartment in which the substance will likely be
found. A way to determine whether a substance
has equivalent toxicity in sediment as in the water
column should be proposed.
Furthermore, information on aquatic toxicity other
than that gathered from standard studies and provided
for in relevant test guidelines, i.e. information from non-
standard studies and non-standard endpoints, could be
used as supporting data. Also, the endocrine disrupting
potential of chemical substances is an issue. It is planned
to develop a general concept for EDCs which should be
consistent and should ensure that endocrine disruptors
are dealt with in a consistent and coordinated manner
across the different regulatory frameworks [52]. This issue
has been discussed by a panel of experts of the German
Table 6 Main elements of our proposal for a harmonized
assessment of toxicity across regulatory frameworks
Toxicity
Definitive assessment Screening assessment
Criteria NOEC (long-term) < 0.01 mg/L,
marine or freshwater species
≥1 value for acute
LC50/EC50 < 0.1 mg/L:
potentially toxic
CMR substances Acute LC50/EC50
values < 0.01 mg/L: toxic
Other evidence of chronic
toxicity
Proposal Other information to consider Other information to
consider
NOEC≤ 30 mg/kg food,
birds and mammals
QSAR












The T criteria for definitive and screening assessments is included.
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considered for inclusion of EDC potential in the harmo-
nised assessment of the T criterion.
Screening assessment. The screening criteria for asses-
sing toxicity are based on short-term (acute) toxicity of
the compound on aquatic organisms. They are as follows:
– A substance with at least one acute LC50/EC50 value
below 0.1 mg/L is considered to be potentially toxic
(potentially T, sometimes called ‘screening T’ under
REACH). This classification can only be revoked by
adequate chronic data, i.e. for determination of
definitive criteria for T [26];
– A substance with acute LC50/EC50 values below 0.01
mg/L is considered to be toxic (T), as NOEC or
EC10 values from prolonged or chronic toxicity
studies will always be below acute LC50 or EC50
values for the same taxon [26].
Other possibilities include the use of QSAR and read-
across from structurally related substances, if testing of the
substance is technically impossible because of its physico-
chemical properties or in cases of data poor situations.
Main outcomes The criteria for the definitive and the
screening assessment of the T criterion are to a large ex-
tent consistent between the different regulatory frame-
works. However, in situations where data availability or
adequacy is too poor to support a definitive or a screen-
ing assessment, we propose that other indications of tox-
icity potential should be taken into account (Table 6).
These include, for example, endpoints from toxicity tests
with terrestrial organisms, endocrine-disrupting proper-
ties, QSAR calculations or harmonised toxicological clas-
sifications. Since trigger values have not yet been set for
these endpoints, a WoE approach is needed to decide on
a case-by-case basis whether a substance fulfils the T cri-
terion as part of PBT assessment.
Considering metabolites and transformation products
Transformation products can be as or even more per-
sistent than their parent compounds and thus must be
included in chemical assessment. However, the regula-
tory frameworks for substances differ with respect to the
inclusion of metabolites or transformation products in
PBT identification. For PPPs, the consideration of me-
tabolites in the context of PBT identification has been
controversially discussed, as PPPs Regulation 1107/2009
[2] does not address this issue precisely and only refers
to the relevance of metabolites in a general sense (Art. 3
(32) Annex II point 3.3). However, a current proposal
envisages excluding metabolites in the process of PBT
identification and in the identification of candidates forsubstitution (i.e. substances that meet two of the three
criteria) [11]. REACH requires that registration docu-
ments for chemicals produced or imported in excess of
100 t/a include information about metabolites and trans-
formation products [54]. They are to be considered in
PBT identification if they exceed 0.1% of the substance
weight [9,26]. For both human and veterinary medicinal
products, transformation products >10% are considered
to be ‘relevant’ and thus included in risk assessment as
well as in PBT assessment. In the assessment of biocides,
major metabolites (≥10% or ≥5% at two consecutive
sampling points or maximum not reached but ≥5% of
the active substance at the final time point) are consid-
ered in PBT identification and minor metabolites only if
data are available or there is any reason for concern. It is
questionable whether relevance can be defined in terms
of any percentage. Since humans and the environment
should be protected from exposure to PBT and vPvB
substances, the same criteria should apply to metabolites
or transformation products as to the parent compounds.
We suggest that in all regulatory frameworks, metabo-
lites and transformation products should be included in
the assessment.
Conclusions
The various European regulatory frameworks on chemical
substances agree that exposure of humans and the envir-
onment to substances identified as PBT or vPvB must be
avoided. But the decision-making process is not straight-
forward and harmonisation between the frameworks is a
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identification of a PBT or vPvB substance will depend on
how the criteria are used in the various frameworks to
determine.
(i) For persistence, the half-lives in terms of e.g.
temperature normalisation, how field studies are
considered, appropriate statistics, and others,
(ii) For bioaccumulation, e.g. the endpoints - in
addition to the BCF for aquatic organisms -
considered in a WoE approach, and
(iii) For toxicity, e.g. indications of toxicity potential
considered when availability or adequacy of data is
too poor to support a definitive or a screening
assessment.
Differences in testing requirements, data availability,
data evaluation and interpretation were screened and dis-
cussed to identify the best methods. The current proposal
is thus characterised by its robustness against those differ-
ences and by its reasonable conservatism.
For example, the proposal for the Persistence criterion
is based on the outcome of an evaluation performed on
a set of selected active substances of PPPs. We recom-
mend (i) normalising the DegT50 values to a temperature
of 12°C as this is established in biocides legislation and
suggested in other regulations (REACH and medicinal
products directives), and (ii) selecting the geometric mean
if five or more DegT50 values are available, or a suitable
value or range of DegT50 values in a WoE approach if the
studies are not equally reliable.
Finally, the differing mandatory measures imposed by
the various regulations should be considered together
with the present proposal on harmonised PBT/vPvB
identification in order to ensure that the truly problem-
atic substances are identified.Abbreviations
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